Marilyn J. Aardema - Concepedia

Author

Marilyn J. Aardema

Also Known As

Aardema, Marilyn, M Aardema, M J Aardema, M. Aardema, M. J. Aardema, M.J. Aardema, Marilyn Aardema, Marilyn J Aardema, Marilyn J. Aardema, Waters, Michael

123

Publications

7.2K

Citations

H-Index

119

Concepts

All Affiliations

Procter & Gamble (United States)National Institute of Health Sciences BioReliance (United States)Sanofi (France)United States Food and Drug Administration

About

Marilyn J. Aardema is an author at Procter & Gamble (United States) specializing in medicine, toxicology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	51	4.6K
2	Engineering	11	11	695
3	Public Health	11	12	557
4	Allergy	7	7	205
5	Health Sciences	4	4	241

Marilyn J. Aardema

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens David Kirkland, Marilyn J. Aardema, L.M. Henderson, Mutation Research/Genetic Toxicology and Environmental Mutagenesis MedicineRodent CarcinogensToxicology TestingToxicologyToxicological Aspect	2005	742
Report from the in vitro micronucleus assay working group Micheline Kirsch‐Volders, Toshio Sofuni, Marilyn J. Aardema, Mutation Research/Genetic Toxicology and Environmental Mutagenesis MedicineBioanalysisAnalytical ChemistryLaboratory ProtocolPharmacology	2003	623
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop David Kirkland, Stefan Pfuhler, David Tweats, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Animal TestingVeterinary ScienceToxicology TestingToxicologyEcvam Workshop	2007	429
Report from the In Vitro Micronucleus Assay Working Group Micheline Kirsch‐Volders, Toshio Sofuni, Marilyn J. Aardema, Environmental and Molecular Mutagenesis ImmunologyPathologyImmunophenotypingCell CultureBioanalysis	2000	284
Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens David Kirkland, Marilyn J. Aardema, Lutz Müller, Mutation Research/Genetic Toxicology and Environmental Mutagenesis MedicineRodent CarcinogensToxicology TestingToxicologyToxicological Aspect	2006	150
Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing V. Thybaud, Marilyn J. Aardema, Julie Clements, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Hazard IdentificationVitro TestingToxicology TestingToxicologyEnvironmental Toxicology	2006	131
SFTG international collaborative study on in vitro micronucleus test Elisabeth Lorge, Véronique Thybaud, Marilyn J. Aardema, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Vitro Micronucleus TestEngineeringBiomedical EngineeringTissue CultureMicrofluidics	2006	128
Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing Ting Hu, Cathy M. Miller, Gregg M. Ridder, Mutation research. Fundamental and molecular mechanisms of mutagenesis Knockout MouseOncogenic AgentApoptosisCell DeathPathology	1999	109
The utility of DNA microarrays for characterizing genotoxicity. Ronald K. Newton, Marilyn J. Aardema, Jiri Aubrecht Environmental Health Perspectives Array-based Expression ProfilingDna DamageGene Expression ProfileMedicineGenetics	2004	109
Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing Masamitu Honma, Andreas Czich, Marilyn J. Aardema, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Vivo Genotoxicity AssessmentPreclinical Drug EvaluationAcute TestsStandard ToxicityPharmacology	2010	105

Page 1